MHH researchers develop regulatory CAR-T cells to combat liver inflammation, neurodegenerative diseases and type 1 diabetes.

Dr Beate Schwinzer is handing over the baton to Dr Olga Halle.

On the path to better therapies: Researchers have established a direct link between centromeres and immunity for the first time.

MHH researchers find antimicrobial peptides on axolotl skin that not only fight dangerous hospital germs but also tumour cells as an effective…

MHH pathologist investigates how gene loss or duplication influence which organs the tumour cells migrate to.

The MHH plus Foundation honours Prof. Dr Markus W. Büchler, Prof. Dr Elisabeth Heßmann and PD Dr Niklas Klümper with the Zimmermann Prize and Medal.

Kurt Alten Foundation supports clinical scientist at MHH in transferring innovative medical-technological approaches to improve liver transplants into…

MHH pneumologist investigates the effect of brensocatib on bronchiectasis disease in ASPEN study.

The Boehringer Ingelheim Foundation is providing 600,000 Euros in funding for basic research into new approaches to the treatment of liver fibrosis…

New hope: MHH researchers are mobilising the immune system's defence against tumour cells within just two weeks using a two-phase vaccination regimen.…